Why Voyager Therapeutics Stock Is Trading Lower Today

Voyager Therapeutics VYGR shares were trading lower on Tuesday after the company reported third-quarter earnings results.

Wells Fargo also downloaded the stock from Overweight to Equal-Weight and announced a price target of $10 per share.

Voyager Therapeutics Inc is functional in the United States biotechnology industry. Its focus lies in the research and development of gene therapies for the cure of severe diseases of the central nervous system such as the Parkinson's, Huntington's and Alzheimer's disease.

Voyager Therapeutics shares were trading down 22.14% at $8.72 on Tuesday. Voyager Therapeutics stock has a 52-week high of $15.26 and a 52-week low of $6.26.